Patient preferences for intervention in the setting of precursor multiple myeloma

• Catherine R. Marinac,
• Katelyn Downey,
• Jacqueline Perry,
• Brittany Fisher-Longden,
• Timothy R. Rebbeck,
• Urvi A. Shah,
• Elizabeth K. O’Donnell,
• Irene M. Ghobrial,
• Omar Nadeem,
• Brian L. Egleston

Affiliations

Catherine R. Marinac

Department of Medical Oncology, Dana-Farber Cancer Institute

Katelyn Downey

Department of Medical Oncology, Dana-Farber Cancer Institute

Jacqueline Perry

Department of Medical Oncology, Dana-Farber Cancer Institute

Brittany Fisher-Longden

Department of Medical Oncology, Dana-Farber Cancer Institute

Timothy R. Rebbeck

Department of Medical Oncology, Dana-Farber Cancer Institute

Urvi A. Shah

Department of Medicine, Memorial Sloan Kettering Cancer Center

Elizabeth K. O’Donnell

Department of Medical Oncology, Dana-Farber Cancer Institute

Irene M. Ghobrial

Department of Medical Oncology, Dana-Farber Cancer Institute

Omar Nadeem

Department of Medical Oncology, Dana-Farber Cancer Institute

Brian L. Egleston

Fox Chase Cancer Center